Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
STIMIT
STIMIT
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
STIMIT
Total Funding
$50.4 K
STIMIT Summary
Company Summary
Overview
STIMIT is a company developing a technology that allows the localized release of cancer immunotherapy in the context of surgical tumor resection. Its product simulates lungs and diaphragm's activity and designed for intensive care patients.
Type
Private
Status
Active
Founded
2018
Website
https://stimittx.com
Cybersecurity rating
Sectors
Technology
biotech
medical devices
oncology
therapy
Homepage
Linkedin
Table of Contents
Competitors
Competitors and Similar Companies
Immunicom
Technology - Private
QV Bioelectronics
Healthcare - Private
AI4R
Technology - Private
NeoTherma Oncology
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top